Showing 1 - 10 of 1,228
Firm turnover has recently attracted increased interest in economic research. The entry of new firms increases competition and promises efficiency gains. Moreover, changes in the market structure influence productivity growth, because firm entry usually leads to increased innovation. The health...
Persistent link: https://www.econbiz.de/10011344853
One of the reasons why regulators are hesitant about permitting price competition in healthcare markets is that it may damage quality when information is poor. Evidence on whether this fear is well-founded is scarce. We provide evidence using a reform that permitted Dutch health insurers and...
Persistent link: https://www.econbiz.de/10012920670
One of the reasons why regulators are hesitant about permitting price competition in healthcare markets is that it may damage quality when information is poor. Evidence on whether this fear is well-founded is scarce. We provide evidence using a reform that permitted Dutch health insurers and...
Persistent link: https://www.econbiz.de/10011823733
We develop a model in which two insurers and two health care providers compete for a fi xed mass of policyholders. Insurers compete in premium and o er coverage against financial consequences of health risk. They have the possibility to sign agreements with providers to establish a health care...
Persistent link: https://www.econbiz.de/10014189391
Over the past years we have witnessed patents related to in vitro diagnostic methods, as well as patents on human genes … questioning of the nature, legitimacy and scope of gene patents and diagnostic methods instrumental to public health. Although …
Persistent link: https://www.econbiz.de/10014188441
U.S. Prison health care has recently been in the news and in the courts. A particular issue is whether prisons should contract out for health care. Contracting out has been growing over the past few decadest. The stated motivation for this change ranges from a desire to improve the prison health...
Persistent link: https://www.econbiz.de/10014049916
This study seeks to provide evidence for deciding whether or not a pharmaceutical innovation should be included in the benefit list of social health insurance. A discrete choice experiment (DCE) was conducted in Germany to measure preferences for modern insulin therapy. Of the 1,100 individuals...
Persistent link: https://www.econbiz.de/10010315493
Suppliers who are better informed than purchasers, such as physicians treating insured patients, often have discretion over what to provide. This paper shows how, when the purchaser observes what is supplied but can observe neither recipient type nor the actual cost incurred, optimal provision...
Persistent link: https://www.econbiz.de/10010261143
This paper studies the impact of hospital competition on waiting times. We use a Salop-type model, with hospitals that differ in (geographical) location and, potentially, waiting time, and two types of patients; high-benefit patients who choose between neighbouring hospitals (competitive...
Persistent link: https://www.econbiz.de/10010264231
Dieser Aufsatz stellt die entscheidungstheoretischen Grundlagen der Produktion von Gesundheitsleistungen dar und leitet daraus Schlussfolgerungen für die Gesundheitspolitik ab. Die bedeutendste Herausforderung am Beginn des 21. Jahrhunderts liegt darin, die Diffusion neuen medizinischen Wissens...
Persistent link: https://www.econbiz.de/10010265431